A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04990037 · COMPLETED
Trial details
- NCT number
- NCT04990037
- Sponsor
- Cantargia AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2023-05-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.